WORCESTER, MA -- (MARKET WIRE) -- May 24, 2007 -- Generex Biotechnology Corporation (NASDAQ: GNBT) announced today that Dr. Douglas Powell, Director of Immunobiology at its wholly owned Antigen Express subsidiary, has presented Antigen's vaccine development strategy at an international conference in London, UK. The international meeting, "Developing New Anti-Infective Agents - Challenges and Opportunities" (www.anti-infectives-forum.com), is being held May 24th and 25th and brings together leading individuals from academia, industry, and regulatory agencies.
